• Amiral, J., Bridey, F., Wolf, M., Boyer-Neumann, C., Fressinaud, E., Vissac, A., Peynaud-Debayle, E., Dreyfus, M. & Meyer, D. (1995) Antibodies to macromolecular platelet factor 4–heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thrombosis and Haemostasis, 73, 2128.
  • Amiral, J., Peynaud-Debayle, E., Wolf, M., Bridey, F., Vissac, A.M. & Meyer, D. (1996a) Generation of antibodies to heparin–PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin. American Journal of Hematology, 52, 9095.
  • Amiral, J., Marfaing-Koka, A., Wolf, M., Alessi, M.C., Tardy, B., Boyer-Neumann, C., Vissac, A.M., Fressinaud, E., Poncz, M. & Meyer, D. (1996b) Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood, 88, 410416.
  • Carlsson, L.E., Santoso, S., Baurichter, G., Kroll, H., Papenberg, S., Eichler, P., Westerdaal, N.A.C., Kiefel, V., Van De Winkel, J.G.J. & Greinacher, A. (1998) Heparin-induced thrombocytopenia: new insights into the impact of the FcγRIIa-R-H131 polymorphism. Blood, 92, 15261531.
  • Eichinger, S., Kyrle, P., Brenner, B., Wagner, B., Kapiotis, S., Lechner, K. & Korninger, H. (1991) Thrombocytopenia associated with low-molecular-weight heparin. Lancet, 337, 14251426.
  • Elalamy, I., Potevin, F., Lecrubier, C., Bara, L., Marie, J. & Samama, M. (1996) A fatal low-molecular-weight heparin-associated thrombocytopenia after hip surgery: possible usefulness of PF4–heparin ELISA test. Blood Coagulation and Fibrinolysis, 7, 665671.
  • Greinacher, A., Michels, I., Liebenhoff, U., Presek, P. & Mueller-Eckhardt, C. (1993) Heparin-associated thrombocytopenia: immune complexes are attached to the platelet membrane by the negative charge of highly sulphated oligosaccharides. British Journal of Haematology, 84, 711716.
  • King, D. & Kelton, J. (1984) Heparin-associated thrombocytopenia. Annals of Internal Medicine, 100, 536540.
  • Lecompte, T., Luo, S., Stieltjes, N., Lecrubier, C. & Samama, M. (1991) Thrombocytopenia associated with low molecular weight heparin. Lancet, 338, 1217.
  • Lindhoff-Last, E., Nakov, R., Misselwitz, F., Breddin, H. & Bauersachs, R. (2002) Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin. British Journal of Haematology, 118, 11371142.
  • Nand, S., Wong, W., Yuen, B., Yetter, A., Schmulbach, E. & Fisher, S.G. (1997) Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution. American Journal of Hematology, 56, 1216.
  • Pouplard, C., Amiral, J., Borg, J.Y., Vissac, A.M., Delahousse, B. & Gruel, Y. (1997) Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium. British Journal of Haematology, 99, 273280.
  • Pouplard, C., May, M.A., Iochmann, S., Amiral, J., Vissac, A.M., Marchand, M. & Gruel, Y. (1999a) Antibodies to platelet factor 4–heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical implications for heparin-induced thrombocytopenia. Circulation, 99, 25302536.
  • Pouplard, C., Amiral, J., Borg, J.Y., Laporte-Simitsidis, S., Delahousse, B. & Gruel, Y. (1999b) Decision analysis for use of platelet aggregation test, carbon 14 serotonin release assay, and heparin–platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia. American Journal of Clinical Pathology, 111, 700706 .
  • DeRaucourt, E., Vinsonneau, C., Juvin, K., Fischer, A.M. & Meyer, G. (1996) Heparin-induced thrombocytopenia with thrombotic complications during prophylactic treatment with low-molecular-weight heparin. Blood Coagulation and Fibrinolysis, 7, 786788.
  • Sheridan, D., Carter, C. & Kelton, J. (1986) A diagnostic test for heparin-induced thrombocytopenia. Blood, 67, 2730.
  • Singer, R., Mannion, J., Bauer, T., Armenti, F. & Edie, R. (1993) Complications from heparin-induced thrombocytopenia in patients undergoing cardiopulmonary bypass. Chest, 104, 14361440.
  • Tardy-Poncet, B., Tardy, B., Reynaud, J., Mahul, P., Mismetti, P., Mazet, E. & Guyotat, D. (1999) Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia. Chest, 115, 16161620.
  • Warkentin, T. (2000) Clinical picture of heparin-induced thrombocytopenia. In: Heparin-Induced Thrombocytopenia (ed. by T.Warkentin & Greinacher, A. ), pp. 4383. Marcel Dekker, New York.
  • Warkentin, T. & Kelton, J. (1994) Interaction of heparin with platelets, including heparin-induced thrombocytopenia. In: Low-Molecular-Weight Heparins in Prophylaxis and Therapy of Thromboembolic Diseases Vol. 19 (ed. by H.Bounameaux), pp. 75127. Marcel Dekker, New York.
  • Warkentin, T.E. & Kelton, J.G. (1996) A 14-year study of heparin-induced thrombocytopenia. American Journal of Medicine, 101, 502507.
  • Warkentin, T.E. & Kelton, J.G. (2001) Temporal aspects of heparin-induced thrombocytopenia. New England Journal of Medicine, 344, 12861292.
  • Warkentin, T., Levine, M., Hirsh, J., Horsewood, P., Roberts, R., Gent, M. & Kelton, J. (1995) Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. New England Journal of Medicine, 332, 13301335.
  • Warkentin, T.E., Chong, B.H. & Greinacher, A. (1998) Heparin-induced thrombocytopenia: towards consensus. Thrombosis and Haemostasis, 79, 17.
  • Warkentin, T.E., Sheppard, J.A., Horsewood, P., Simpson, P.J., Moore, J.C. & Kelton, J.G. (2000) Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood, 96, 17031708.